Vicarious Surgical (RBOTW) Cash & Equivalents (2020 - 2025)

Vicarious Surgical (RBOTW) has 6 years of Cash & Equivalents data on file, last reported at $2.6 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $2.6 million, down 73.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 million (down 73.62% YoY), and the FY2025 annual result was $2.6 million, down 73.62% from the prior year.
• Cash & Equivalents fell to $2.6 million in Q4 2025 per RBOTW's latest filing, from $3.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $185.0 million in Q3 2021 and troughed at $1.0 million in Q1 2021.
• A 5-year average of $66.2 million and a median of $51.4 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents surged 15173.98% in 2022, then slumped 90.67% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $173.5 million in 2021, then plunged by 33.02% to $116.2 million in 2022, then sank by 54.55% to $52.8 million in 2023, then plunged by 81.57% to $9.7 million in 2024, then plunged by 73.62% to $2.6 million in 2025.
• Business Quant data shows RBOTW's Cash & Equivalents at $2.6 million in Q4 2025, $3.2 million in Q3 2025, and $24.0 million in Q2 2025.